Northern Trust’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
324,538
+147,258
| +83% | +$574K | ﹤0.01% | 3256 |
|
|
2025
Q1 | $672K | Sell |
177,280
-2,912
| -2% | -$11K | ﹤0.01% | 3450 |
|
|
2024
Q4 | $978K | Buy |
180,192
+59,902
| +50% | +$325K | ﹤0.01% | 3404 |
|
|
2024
Q3 | $504K | Sell |
120,290
-99
| -0.1% | -$415 | ﹤0.01% | 3579 |
|
|
2024
Q2 | $355K | Sell |
120,389
-7,430
| -6% | -$21.9K | ﹤0.01% | 3631 |
|
|
2024
Q1 | $354K | Sell |
127,819
-5,814
| -4% | -$16.1K | ﹤0.01% | 3683 |
|
|
2023
Q4 | $380K | Buy |
133,633
+43,933
| +49% | +$125K | ﹤0.01% | 3640 |
|
|
2023
Q3 | $231K | Buy |
89,700
+7,540
| +9% | +$19.5K | ﹤0.01% | 3751 |
|
|
2023
Q2 | $355K | Sell |
82,160
-8,665
| -10% | -$37.4K | ﹤0.01% | 3627 |
|
|
2023
Q1 | $139K | Sell |
90,825
-2,243
| -2% | -$3.43K | ﹤0.01% | 3987 |
|
|
2022
Q4 | $147K | Buy |
93,068
+2,814
| +3% | +$4.45K | ﹤0.01% | 3981 |
|
|
2022
Q3 | $112K | Sell |
90,254
-11,450
| -11% | -$14.2K | ﹤0.01% | 4077 |
|
|
2022
Q2 | $206K | Buy |
101,704
+1,762
| +2% | +$3.57K | ﹤0.01% | 3910 |
|
|
2022
Q1 | $250K | Sell |
99,942
-1,341
| -1% | -$3.35K | ﹤0.01% | 4044 |
|
|
2021
Q4 | $378K | Buy |
101,283
+15,713
| +18% | +$58.6K | ﹤0.01% | 3910 |
|
|
2021
Q3 | $343K | Buy |
85,570
+375
| +0.4% | +$1.5K | ﹤0.01% | 3917 |
|
|
2021
Q2 | $379K | Buy |
85,195
+169
| +0.2% | +$752 | ﹤0.01% | 3836 |
|
|
2021
Q1 | $778K | Sell |
85,026
-35,963
| -30% | -$329K | ﹤0.01% | 3679 |
|
|
2020
Q4 | $1.23M | Buy |
120,989
+4,222
| +4% | +$42.8K | ﹤0.01% | 3432 |
|
|
2020
Q3 | $495K | Buy |
116,767
+20,896
| +22% | +$88.6K | ﹤0.01% | 3609 |
|
|
2020
Q2 | $664K | Buy |
95,871
+83,406
| +669% | +$578K | ﹤0.01% | 3478 |
|
|
2020
Q1 | $35K | Buy |
+12,465
| New | +$35K | ﹤0.01% | 4007 |
|